Skip to main
MEDP

Medpace Holdings (MEDP) Stock Forecast & Price Target

Medpace Holdings (MEDP) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 9%
Hold 64%
Sell 9%
Strong Sell 18%

Bulls say

Medpace Holdings is poised for growth, with expectations of passthrough revenues increasing by 200-300 basis points in the second half of the year compared to elevated levels in the second quarter. The company experienced a strong first quarter characterized by higher request for proposal (RFP) volumes, indicating robust demand in its sector. Furthermore, there is strong potential for Medpace’s book-to-bill ratio to return to above 1.15x in the third quarter, signaling a positive outlook for future revenues and operational performance.

Bears say

Medpace Holdings has exhibited signs of financial instability, as reflected in its backlog cancellations remaining at or above normal levels, although they have recently declined toward the lower end of expectations. Furthermore, the company has expressed uncertainty regarding the growth of its Direct Service revenue, indicating that it is premature to provide quantifiable forecasts, despite not anticipating a significant decline in 2026. Updated projections for adjusted EBITDA for 2025 and 2026 have increased, yet the adjustments appear to stem from rising direct service costs and an expected decrease in passthroughs, which may signal underlying operational challenges.

Medpace Holdings (MEDP) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 9% advise Selling, and 18% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medpace Holdings (MEDP) Forecast

Analysts have given Medpace Holdings (MEDP) a Hold based on their latest research and market trends.

According to 11 analysts, Medpace Holdings (MEDP) has a Hold consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $479.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $479.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medpace Holdings (MEDP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.